ID: ALA4800224

Max Phase: Preclinical

Molecular Formula: C22H21N3O2

Molecular Weight: 359.43

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cccc(-c2nnc3ccc(-c4cccc(OC(C)C)c4)cn23)c1

Standard InChI:  InChI=1S/C22H21N3O2/c1-15(2)27-20-9-4-6-16(12-20)18-10-11-21-23-24-22(25(21)14-18)17-7-5-8-19(13-17)26-3/h4-15H,1-3H3

Standard InChI Key:  BLVBQPHYSKXTBT-UHFFFAOYSA-N

Associated Targets(non-human)

Schistosoma mansoni 6170 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 4.86#Rotatable Bonds: 5
Polar Surface Area: 48.65Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.86CX LogP: 3.93CX LogD: 3.93
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -1.43

References

1. J. Mark F. Gardner, Nuha R. Mansour, Andrew S. Bell, Helena Helmby, Quentin Bickle.  (2021)  The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species,  [PMID:34280206] [10.1371/journal.pntd.0009490 ]